Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women2011 Update: A Guideline From the American Heart Association Lori Mosca, Emelia J. Benjamin, Kathy Berra, Judy L. Bezanson, Rowena J. Do

First Page		Document Content
Date: 2011-06-04 10:25:33 Cardiology Heart Framingham Risk Score Cardiovascular disease Nutrition Myocardial infarction Metabolic syndrome Coronary artery disease Lipoprotein Health Medicine Aging-associated diseases		Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women2011 Update: A Guideline From the American Heart Association Lori Mosca, Emelia J. Benjamin, Kathy Berra, Judy L. Bezanson, Rowena J. Do Add to Reading List Source URL: asnc.org Download Document from Source Website File Size: 1,39 MB Share Document on Facebook

	CORPORATE FACT SHEET CORPORATE PROFILE Gamma Therapeutics, Inc., incorporated as a “C” corporation in Portland, Oregon, USA, October, 2009, is an early stage biotechnology venture developing a novel class of biop DocID: 1p9dX - View Document
	00 UG Suppl 15.qxp, page 1 @ Preflight DocID: 1oB41 - View Document
	Distribution of Coronary Artery Calcium by Race, Gender, and Age Results from the Multi-Ethnic Study of Atherosclerosis (MESA) Robyn L. McClelland, PhD; Hyoju Chung, MS; Robert Detrano, MD; Wendy Post, MD, MS; Richard A. DocID: 1aXM7 - View Document
	Core Journal Life Science Publishing Tokyo, Japan Interview with Dr. Stephen L. Kopecky Cardiovascular Health Clinic Department of Cardiovascular Diseases DocID: 1axmS - View Document
	Wimmera Mail Times, Horsham VIC 05 Feb 2014 Supplements, pagecm² Regional - circulation 8,227 (M-W-F--) Copyright Agency licensed copy (www.copyright.com.au) DocID: 18QWb - View Document